212 papers
Immunology explores the intricate defense systems that keep our bodies safe from infections and disease. This field examines how our immune cells recognize threats, coordinate responses, and maintain a delicate balance between fighting invaders and avoiding self-harm. From understanding vaccine mechanisms to investigating autoimmune disorders, these studies reveal the dynamic biology protecting human health every day.
On Gist.Science, we ensure these critical discoveries remain accessible to everyone. We automatically process every new preprint in this category as it appears on bioRxiv, transforming complex research into both plain-language explanations and detailed technical summaries. This approach allows readers to grasp the core findings without getting lost in dense jargon, while still providing the depth needed for scientific inquiry.
Below are the latest immunology papers from bioRxiv, each accompanied by our curated summaries to help you navigate the newest breakthroughs in the field.
This study demonstrates that a safe, adaptable single-cycle SARS-CoV-2 vaccine candidate engineered with an XBB.1.5 Spike protein effectively prevents disease and blocks viral transmission in animal models, outperforming current bivalent mRNA vaccines.
This study demonstrates that GonoVac, a candidate native gonococcal outer membrane vesicle vaccine, elicits superior functional immune responses and serum bactericidal activity against *Neisseria gonorrhoeae* in mice and rabbits compared to the meningococcal vaccine 4CMenB, supporting its further development as a promising preventive measure for gonorrhea.
Using single-cell RNA sequencing of cerebrospinal fluid from HIV-associated tuberculous meningitis patients, this study identifies a hyperinflammatory pathology characterized by the accumulation of granzyme-rich cytotoxic CD8 T cells, highly activated neutrophils, and detrimental type 1 interferon signaling that correlates with bacterial load and treatment response.
This pilot study establishes a new porcine model of irreversible anaphylactic shock by demonstrating that hemoperfusion with a carbon-cellulose cartridge (Adsorba® 300C) triggers a fatal, complement-mediated pseudoallergic reaction characterized by profound hemodynamic collapse, thereby providing a clinically relevant system to investigate extracorporeal circulation-induced immune responses.
This study demonstrates that displaying the *E. coli* FimH antigen on I53-50 nanoparticles significantly enhances its immunogenicity, eliciting robust receptor-blocking antibodies in mice and non-human primates comparable to high-dose monomeric formulations, thereby validating a promising nanoparticle-based vaccine strategy for preventing urinary tract infections.
This study reveals that HIV-1 Vpr promotes infection by inducing the degradation of the restriction factor TASOR, which inhibits viral replication prior to integration, thereby overcoming a critical host defense mechanism through a process dependent on CRL4-DCAF1 interaction and nuclear localization.
This study demonstrates that selective JAK2 inhibition, rather than broad or JAK3-targeted approaches, is the most effective strategy for treating AIRE-deficiency-driven autoimmunity by directly suppressing the dominant IFN-γ signaling axis while preserving other essential immune functions.
This study reveals that during *Plasmodium* infection, multiple temporally overlapping mechanisms—including Myc-driven expansion, early class switch recombination, and germinal center-mediated somatic hypermutation—combinatorially diversify individual B cell clones to amplify and safeguard humoral immunity, while anti-malarial treatment limits the magnitude but not the rate of this diversification.
This study demonstrates that GM-CSF acts as a critical spatial regulator in Crohn's disease by mediating myeloid-lymphoid crosstalk to restrain ILC1 expansion, sustain ILC3 maintenance, and promote IL-22 production, thereby limiting epithelial injury and inflammation in ulcerated intestinal regions.
This study identifies the long non-coding RNA Dreg1 as a Tcf1-dependent regulator essential for fine-tuning Gata3 expression to ensure the optimal development of group 2 innate lymphoid cells (ILC2) while leaving other lymphoid lineages unaffected.